DR. MABANAG - MACROLIDES, CLINDAMYCIN, CHLORAMPHENICOL, STREPTOGRAMINS & OXAZOLIDINONES Flashcards

1
Q

A group of closely related compounds characterized by a long macrocyclic lactone ring (usually containing 14 or 16 atoms) to which deoxy sugars are attached.

A

MACROLIDES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

● Prototype drug consists of 2 sugar moieties attached to a 14-atom lactone ring
● Obtained in 1952 from Streptomyces erythraeus now called as Saccharopolyspora erythraea

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

discovered in Iloilo City by Dr. Abelardo Aguilar but not given the credit

A

Streptomyces erythraeus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

first brand name of Erythromycin because it was discovered in Iloilo City.

A

ILOSONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are semi-synthetic derivatives of erythromycin

A

CLARITHROMYCIN
AZITHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

○ Inhibition of protein synthesis occurs via
binding to the 50S ribosomal RNA
- Activities enhanced at alkaline pH

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

● Active against susceptible strains of G(+) organisms especially pneumococci, streptococci, and the corynebacteria.
○ Mycoplasma pneumoniae
○ Legionella pneumophila
○ Chlamydia trachomatis
○ Chlamydophila psittaci
○ Chlamydophila pneumoniae
○ H. pylori
○ Listeria monocytogenes

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

● Certain mycobacteria are also susceptible
(non-tuberculous mycobacteria):
○ Mycobacterium kansasii
○ Mycobacterium scrofulaceum

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

● Gram-negative organisms susceptible strain
○ Neisseria sp
○ Bordatella pertussis
○ Bartonella henselae
○ Bartonella quintana

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

● Rickettsia species
○ Treponema pallidum
○ Campylobacter species
● Haemophilus influenzae is somewhat less
susceptible

A

ERYTHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MACROLIDES PHARMACOKINETICS

A
  • DESTROYED BY STOMACH ACIDS
  • FOOD INTERFERES WITH ABSORPTION
  • NOT REMOVED BY DIALYSIS
  • BILE EXCRETION
  • CAN CROSS PLACENTA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MACROLIDES ADVERSE REACTIONS

A
  1. GI SYMPTOMS
  2. GI INTOLERANCE
  3. ACUTE CHOLESTATIC HEPATITIS
  4. INHIBITS CYP450
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

= ↑ serum concentration of theophylline, warfarin, cyclosporine, and methylprednisolone so decrease the dose

A

Inhibits CYP450 system
MACROLIDES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

for cardiac rhythm abnormalities

A

DIGOXIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

● Derived from erythromycin by addition of a methyl group with ↑ stability in oral absorption
● Same mechanism of action and spectrum activity with erythromycin, except: clarithromycin is more active vs Mycobacterium avium complex

A

CLARITHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Major metabolite: 14-hydroxyclarithromycin; has antibacterial activity and is eliminated in the urine

A

CLARITHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

● A 15-atom lactone macrolide ring compound derived from erythromycin by addition of a methylated nitrogen into lactone ring

A

AZITHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

do not alter bioavailability but delay absorption and ↓ peak serum concentrations

A

Al- and Mg3 (Aluminum and magnesium) antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Does not inactivate CYP450 compared to
erythromycin and clarithromycin (lesser
drug interactions)

A

AZITHROMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Semisynthetic, 14-membered-ring macrolides, differing from erythromycin by substitution by substitution of a 3-keto group for the neutral sugar L-cladinose

A

KETOLIDES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

● Active in vitro vs
○ Streptococcus pyogenes
○ S. pneumoniae
○ S. aureus
○ H. influenza
○ Moraxella catarrhalis
○ Mycoplasma spp.
○ L. pneumophila
○ Chlamydia sp.
○ H. pylori
○ Neisseria gonorrhoeae
○ B. fragilis
○ T. gondii
○ Certain nontuberculous bacteria

A

KETOLIDES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

causes QT prolongation

A

Erythromycin, Clarithromycin, Azithromycin, & Ketolides (Telithromycin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

● More widely used
● Chlorine-substituted derivative of Lincomycin

A

CLINDAMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

** parent compound of clindamycin

A

LINCOMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

○ Interfere with: formation of initiation complexes; aminoacyl translocation
reactions
○ 50s binding site

A

CLINDAMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

○ Susceptible: Streptococci, staphylococci,
pneumococci inhibited by clindamycin
○ Resistant: Enterococci and Gram-negative
aerobic organisms

A

CLINDAMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

○ Penetrates well into abscesses - actively
taken up and concentrated by phagocytic cells

A

CLINDAMYCIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

○ Skin and soft tissue infections caused by streptococci and staphylococci
○ May be active vs strains of CAMRSA (Community-acquired Methicillin-Resistant
Staphylococcus aureus) - may be hospital/community-acquired

A

CLINDAMYCIN

29
Q

○ Commonly used in conjugation with Pen G to treat TSS (Toxic Shock Syndrome) or necrotizing fasciitis caused by Group A Streptococcus

A

CLINDAMYCIN

30
Q
  • Penetrating wounds of the abdomen and the gut
  • Infections originating in the female genital tract, e.g. septic abortion, pelvic abscesses, or PID (Pelvic Inflammatory Disease); and
  • Lung and periodontal abscesses
A

Clindamycin + aminoglycosides or
cephalosporin:

31
Q

effective alternative to TMP-SMX (if the patient is allergic) for moderate to moderately severe Pneumocystis jiroveci (prev. Pneumocystis carinii) pneumonia in AIDS patients

A

Clindamycin + primaquine

32
Q

○ Used in combination with pyrimethamine for AIDS-related brain toxoplasmosis

A

CLINDAMYCIN

33
Q

Adverse Effects CLINDAMYCIN

A

○ Diarrhea (and colitis due to Clostridium difficile)
○ Nausea
○ Rashes
○ Impaired liver function
○ Neutropenia (occasional) - decreased WBC

34
Q

● 50S attacher; reserve drug used for Vancomycin-Resistant MRSA

A

Streptogramins:Quinupristin-Dalfopristin

35
Q

Combination of two streptogramins (Ratio 30:70)
○ Quinupristin - streptogramin A OR B?
○ Dalfopristin - streptogramin A OR B?

A

○ Quinupristin - streptogramin A
○ Dalfopristin - streptogramin B

36
Q

● Rapid bactericidal for most susceptible organisms
○ Except Enterococcus faecium (slow kill)
*NOT faecalis
○ But rapidly skills other susceptible
organisms

A

Streptogramins:Quinupristin-Dalfopristin

37
Q

○ ↓ dose for hepatic insufficiency
- Significantly inhibits CYP3A4
● CYP3A4 metabolizes warfarin, diazepam, quetiapine, simvastatin,
CSA (Cyclosporin A)
● Decrease the dose in patients with liver failure
or alcoholism
- Dose reduction of CSA may be necessary
○ Reduce dose of immunosuppressants in transplant patients

A

Streptogramins:Quinupristin-Dalfopristin

38
Q

● Active vs Gram + cocci
○ Including MDR (multidrug resistant) strains
of Streptococci, penicillin-resistant strains of S. pneumoniae, MSSA (Methicillin-Sensitive Staphylococcus aureus), MRSA, and E. faecium
○ Resistance due to modification of the quinupristin binding site (MLS-B type resistance), enzymatic inactivation of dalfopristin, or efflux

A

Streptogramins:Quinupristin-Dalfopristin

39
Q

Soluble in alcohol, poorly soluble in H20

● Inactivated via conjugation with glucuronic acid or by
reduction to inactive arylamines

A

CHLORAMPHENICOL

40
Q

○ Inhibitor of microbial protein synthesis
○ Bacteriostatic vs most susceptible
organisms:
- H. influenzae, N. meningitidis,
Bacteroides strains (highly
susceptible)

A

CHLORAMPHENICOL

41
Q

○ Binds reversibly to ribosomal 50S
- Inhibits peptide bond formation ○ Broad spectrum

A

CHLORAMPHENICOL

42
Q

Active vs rickettsiae, but not Chlamydiae

A

CHLORAMPHENICOL

43
Q
  • TYPHOID OR ENTERIC FEVER
  • Rickettsial infections such as typhus and RMSF (Rocky Mountain Spotted Fever)
  • ALTERNATIVE FOR BETA LACTAMS FOR BACTERIAL MENINGITIS IN PATIENTS WITH MAJOR HYPERSENSITIVITY RXNS TO PENICILLIN
A

CHLORAMPHENICOL

44
Q

CHLORAMPHENICOL ADVERSE EFFECTS
—-result of alteration of the normal microbial flora

A

Oral or vaginal candidiasis

45
Q

CHLORAMPHENICOL ADVERSE EFFECTS

Dose-related (>50 mg/kg/d) reversible suppression of RBC production after 1-2 weeks →

A

APLASTIC ANEMIA

46
Q

CHLORAMPHENICOL ADVERSE EFFECTS

  • Newborn infants lack an effective glucuronic acid conjugation mechanism for degradation and detoxification of chloramphenicol
A

Gray Baby Syndrome

47
Q

Side effects: Inhibits hepatic microsomal enzymes → prolong serum concentration of phenytoin, tolbutamide, chlorpropamide, warfarin (presence of
drug reactions)

A

chloramphenicol

48
Q

○ Inhibits protein synthesis by preventing formation of ribosome complex that initiates protein synthesis
○ Unique binding site, located on the 23s (sub member) ribosomal RNA of the 50s subunit, results in no cross-resistance with other drug classes

A

LINEZOLID (OXAZOLIDINONES)

49
Q

○ Resistance caused by mutation of the Linezolid binding site on 23s ribosomal RNA

A

LINEZOLID

50
Q

○ Active vs:
- G (+) organisms including
Staphylococci, Streptococci,
Enterococci
- G (+) anaerobic cocci, and
- G (+) rods: corynebacteria, Nocardia sp., Listeria
monocytogenes

A

LINEZOLID

51
Q

○ Primarily a bacteriostatic agent but is bactericidal against Streptococci
○ Active vs Mycobacterium tuberculosis; for MDR TB [Multidrug-resistant Tuberculosis] - second line or last line treatment only

A

LINEZOLID

52
Q

● Remember: It is only a reserve drug. Use it only when Vancomycin and other drugs are not effective.
● Sometimes, this drug is considered as one of the last line treatments for MRSA and MDR TB.

A

LINEZOLID

53
Q

○ HCAP (Health Care-associated Pneumonia) or CAP [Community-acquired pneumonia]
○ VRE (Vancomycin-Resistant Enterococcus)
faecium

A

LINEZOLID

54
Q

○ Off-label uses: treatment of MDR TB; nocardia infections

A

LINEZOLID

55
Q

LINEZOLID ADVERSE EFFECTS

A
  • HEMATOLOGIC
  • THROMBOCYTOPENIA
  • ANEMIA& NEUTROPENIA
56
Q

LINEZOLID ADVERSE EFFECT

usually seen in patients co-administered with serotonergic drugs most frequently selective serotonin uptake inhibitor antidepressant agents

A

SEROTONIN SYNDROME

57
Q

● Active moiety of prodrug tedizolid phosphate - high potency against Gram (+) bacteria, MRSA

A

TEDIZOLID

58
Q

● Potential Advantages (vs Linezolid)
○ ↑ potency vs staphylococci
○ ↓ risk of bone marrow suppression
○ ↓ risk of serotonergic activity
○ ↑ protein-bound (70-90% - higher protein
binding) > Linezolid (31%)

A

TEDIZOLID

59
Q

1.This drug penetrates well in abscesses and is used in combination with Penicillin G to treat Toxic Shock Syndrome.
A. Clindamycin
B. Erythromycin
C. Streptogramins
D. Linezolid
E. Azithromycin

A

A. Clindamycin

60
Q
  1. What is the clinical use of Clindamycin?
    A. Penetrating wounds of the abdomen and gut
    B. Skin and soft tissue infections
    C. Abscesses
    D. Infections originating in the female genital tract
    E. All of the above
A

E. All of the above

61
Q
  1. What is the main route of excretion for erythromycin where the majority of it gets excreted?
    A. Urine
    B. Bile
    C. Dialysis
    D. Stomach acids
    E. CSF
A

B. BILE

62
Q
  1. Which drug has the same mechanism of action as Erythromycin but is more tolerated in the gastrointestinal tract?
    A. Azithromycin
    B. Clindamycin
    C. Clarithromycin
    D. Azithromycin
    E. Linezolid
A

C. Clarithromycin

63
Q
  1. Which statement about the pharmacokinetics of Azithromycin is NOT TRUE?
    A. It does not inactivate CYP450 enzymes, therefore free of the drug interactions that occur with erythromycin and clarithromycin
    B. Rapidly absorbed and well tolerated orally
    C. Slowly released from tissues with a tissue half-life of 2-4 days
    D. Penetrates well into most tissues including the CSF and phagocytic cells
A

D. Penetrates well into most tissues including the CSF and phagocytic cells

64
Q
  1. The following are adverse effects of Chloramphenicol, except
    A. Gray Baby Syndrome in newborn infants B. Oral or vaginal candidiasis
    C. Aplastic anemia
    D. Nausea, vomiting, and diarrhea
    E. None of the above
A

E. None of the above

65
Q
  1. T/F. Streptogramins rapidly eradicate susceptible
    organisms including Enterococcus faecium
A

FALSE

66
Q
  1. What is the unique binding site of Linezolid?
    A. 28S Ribosomal RNA
    B. 26S Ribosomal RNA
    C. 23S Ribosomal RNA
    D. 16S Ribosomal RNA
A

C. 23S Ribosomal RNA

67
Q
  1. What newer generation Oxazolidinone has a lower risk of serotonergic activity thereby preventing the risk for the development of Serotonergic Syndrome?
    A. Linezolid
    B. Chloramphenicol
    C. Tedizolid
    D. Cycloserine
A

C. Tedizolid

68
Q
  1. The following statements are true regarding the clinical use of Chloramphenicol, except
    A. Used for the treatment of rickettsial infections
    B. Used for the treatment of typhoid fever in the Philippines
    C. Used for the treatment of bacterial meningitis
    D. Used for the treatment of chlamydial infections
A

D. Used for the treatment of chlamydial infections